Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Accounts of Chemical Research
|
March 6, 2015
Function through synthesis-informed design
Paul A Wender, Ryan V Quiroz, Matthew C Stevens
Nature Chemistry
|
April 24, 2014
Structural complexity through multicomponent cycloaddition cascades enabled by dual-purpose, reactivity regenerating 1,2,3-triene equivalents
Paul A Wender, Dennis N Fournogerakis, Matthew S Jeffreys, et al.
Organic Chemistry Frontiers : an International Journal of Organic Chemistry
|
January 30, 2015
Function through bio-inspired, synthesis-informed design: step-economical syntheses of designed kinase inhibitors†Dedicated to Max Malacria, a friend and scholar whose science and creative contributions to step-economical synthesis have inspired us all and moved the field closer to the ideal.‡Electronic supplementary information (ESI) available: Synthetic procedures and spectral data. See DOI: 10.1039/c4qo00228hClick here for additional data file
Paul A Wender, Alison D Axtman, Jennifer E Golden, et al.
Science (New York, N.Y.)
|
October 14, 2017
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV
Paul A Wender, Clayton T Hardman, Stephen Ho, et al.
The Journal of Organic Chemistry
|
March 23, 2021
Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4-<i>b</i>]furan Nucleoside Analogues
David A Candito, Yingchun Ye, Ryan V Quiroz, et al.
Journal of Medicinal Chemistry
|
April 30, 2026
Design of Novel Exatecan-Amide Linker-Payloads for the Development of Stable, Low-Aggregating, and Highly Efficacious Antibody-Drug Conjugates
Ryan V Quiroz, Simon B Lang, Rebecca E Johnson, et al.
Journal of Medicinal Chemistry
|
April 30, 2026
Discovery of Novel <i>N</i>-Linked Camptothecin Linker-Payloads to Access Antibody-Drug Conjugates with High Target-Mediated In Vivo Efficacy
Vlad Bacauanu, Si-Jie Chen, Simon B Lang, et al.
Journal of Medicinal Chemistry
|
March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Accounts of Chemical Research
|
March 6, 2015
Function through synthesis-informed design
Paul A Wender, Ryan V Quiroz, Matthew C Stevens
Nature Chemistry
|
April 24, 2014
Structural complexity through multicomponent cycloaddition cascades enabled by dual-purpose, reactivity regenerating 1,2,3-triene equivalents
Paul A Wender, Dennis N Fournogerakis, Matthew S Jeffreys, et al.
Organic Chemistry Frontiers : an International Journal of Organic Chemistry
|
January 30, 2015
Function through bio-inspired, synthesis-informed design: step-economical syntheses of designed kinase inhibitors†Dedicated to Max Malacria, a friend and scholar whose science and creative contributions to step-economical synthesis have inspired us all and moved the field closer to the ideal.‡Electronic supplementary information (ESI) available: Synthetic procedures and spectral data. See DOI: 10.1039/c4qo00228hClick here for additional data file
Paul A Wender, Alison D Axtman, Jennifer E Golden, et al.
Science (New York, N.Y.)
|
October 14, 2017
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV
Paul A Wender, Clayton T Hardman, Stephen Ho, et al.
The Journal of Organic Chemistry
|
March 23, 2021
Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4-<i>b</i>]furan Nucleoside Analogues
David A Candito, Yingchun Ye, Ryan V Quiroz, et al.
Journal of Medicinal Chemistry
|
April 30, 2026
Design of Novel Exatecan-Amide Linker-Payloads for the Development of Stable, Low-Aggregating, and Highly Efficacious Antibody-Drug Conjugates
Ryan V Quiroz, Simon B Lang, Rebecca E Johnson, et al.
Journal of Medicinal Chemistry
|
April 30, 2026
Discovery of Novel <i>N</i>-Linked Camptothecin Linker-Payloads to Access Antibody-Drug Conjugates with High Target-Mediated In Vivo Efficacy
Vlad Bacauanu, Si-Jie Chen, Simon B Lang, et al.
Journal of Medicinal Chemistry
|
March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Page
of 1